Stifel Nicolaus Increases Vital Farms (NASDAQ:VITL) Price Target to $42.00

Vital Farms (NASDAQ:VITL) had its price objective lifted by Stifel Nicolaus from $40.00 to $42.00 in a report issued on Tuesday, Benzinga reports. The brokerage currently has a hold rating on the stock.

Several other equities research analysts have also weighed in on the company. William Blair assumed coverage on Vital Farms in a research report on Wednesday, April 10th. They set an outperform rating on the stock. TD Cowen boosted their target price on shares of Vital Farms from $19.00 to $37.00 and gave the company a hold rating in a report on Friday, May 10th. Lake Street Capital upped their target price on shares of Vital Farms from $26.00 to $32.00 and gave the stock a buy rating in a research report on Wednesday, April 24th. Finally, DA Davidson lifted their price target on shares of Vital Farms from $28.00 to $45.00 and gave the company a buy rating in a research report on Monday, May 13th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Vital Farms has an average rating of Moderate Buy and an average target price of $34.80.

Vital Farms Stock Performance

Shares of NASDAQ:VITL opened at $37.12 on Tuesday. The company has a current ratio of 3.10, a quick ratio of 2.66 and a debt-to-equity ratio of 0.05. The company has a 50-day moving average price of $42.21 and a 200-day moving average price of $28.60. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 43.67 and a beta of 0.98. Vital Farms has a 12 month low of $10.30 and a 12 month high of $48.41.

Vital Farms (NASDAQ:VITL) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.20. Vital Farms had a return on equity of 19.58% and a net margin of 7.48%. The company had revenue of $147.93 million during the quarter, compared to analyst estimates of $139.87 million. As a group, equities analysts anticipate that Vital Farms will post 0.98 EPS for the current year.

Insider Activity

In related news, CEO Russell Diez-Canseco sold 9,735 shares of the company’s stock in a transaction dated Wednesday, May 8th. The shares were sold at an average price of $30.00, for a total value of $292,050.00. Following the transaction, the chief executive officer now owns 403,693 shares in the company, valued at approximately $12,110,790. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CEO Russell Diez-Canseco sold 9,735 shares of the firm’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $30.00, for a total transaction of $292,050.00. Following the completion of the sale, the chief executive officer now owns 403,693 shares of the company’s stock, valued at $12,110,790. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Joanne Bal sold 2,597 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The shares were sold at an average price of $40.71, for a total value of $105,723.87. Following the completion of the transaction, the insider now directly owns 59,101 shares in the company, valued at $2,406,001.71. The disclosure for this sale can be found here. Insiders sold 203,056 shares of company stock worth $8,275,393 over the last three months. 30.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Vital Farms

Several institutional investors have recently modified their holdings of the business. 1620 Investment Advisors Inc. purchased a new position in Vital Farms in the 2nd quarter worth about $42,000. CWM LLC lifted its position in Vital Farms by 162.9% during the second quarter. CWM LLC now owns 1,057 shares of the company’s stock valued at $49,000 after purchasing an additional 655 shares during the period. Tower Research Capital LLC TRC lifted its position in Vital Farms by 211.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,175 shares of the company’s stock valued at $97,000 after purchasing an additional 4,192 shares during the period. DekaBank Deutsche Girozentrale purchased a new stake in Vital Farms in the fourth quarter worth approximately $127,000. Finally, New York State Common Retirement Fund grew its position in Vital Farms by 49.0% in the 4th quarter. New York State Common Retirement Fund now owns 10,169 shares of the company’s stock worth $160,000 after purchasing an additional 3,346 shares during the period. 98.59% of the stock is owned by hedge funds and other institutional investors.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.